Anti immune complex antibody for determining SLE, rheumatoid arthritis or tetanus
US4544640A · kind A · utility
20Cited by
4References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 7, 1983 |
| Grant date | Oct 1, 1985 |
| Priority date | — |
| Expiry date | Apr 7, 2003 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/868
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
An antibody is obtained by using as an antigen a complex of an antigen and the F(ab').sub.2 fragment of the human antibody of this antigen or an aggregate of the F(ab').sub.2 fragment of human immunoglobulin. This antibody reacts with an immune complex in a blood serum of a patient of systemic lupus erythematosus and with an immune complex in a blood serum of a patient of rheumatoid arthritis, and it does not react with an aggregated IgG. The amount of immune complex in a blood serum is easily and exactly determined by using this antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.